JP2022528566A5 - - Google Patents
Info
- Publication number
- JP2022528566A5 JP2022528566A5 JP2021560499A JP2021560499A JP2022528566A5 JP 2022528566 A5 JP2022528566 A5 JP 2022528566A5 JP 2021560499 A JP2021560499 A JP 2021560499A JP 2021560499 A JP2021560499 A JP 2021560499A JP 2022528566 A5 JP2022528566 A5 JP 2022528566A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- age
- amd
- diabetic retinopathy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962828616P | 2019-04-03 | 2019-04-03 | |
| US62/828,616 | 2019-04-03 | ||
| US201962899279P | 2019-09-12 | 2019-09-12 | |
| US62/899,279 | 2019-09-12 | ||
| PCT/CN2020/082765 WO2020200241A1 (en) | 2019-04-03 | 2020-04-01 | Method for treating ocular diseases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022528566A JP2022528566A (ja) | 2022-06-14 |
| JP2022528566A5 true JP2022528566A5 (enExample) | 2022-09-06 |
| JP7461663B2 JP7461663B2 (ja) | 2024-04-04 |
Family
ID=72662774
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021560499A Active JP7461663B2 (ja) | 2019-04-03 | 2020-04-01 | 眼疾患の処置方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11033603B2 (enExample) |
| EP (1) | EP3946414B1 (enExample) |
| JP (1) | JP7461663B2 (enExample) |
| CN (1) | CN113795268B (enExample) |
| SG (1) | SG11202110659SA (enExample) |
| TW (1) | TWI818168B (enExample) |
| WO (1) | WO2020200241A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI788083B (zh) * | 2021-11-03 | 2022-12-21 | 葡萄王生技股份有限公司 | 蟬花菌絲體活性物質用於治療黃斑部病變之用途 |
| US20240316144A1 (en) * | 2023-03-20 | 2024-09-26 | ZIH YUAN TANG Biotechnology Co, Ltd. | Pharmaceutical composition and method for inhibiting angiogenesis |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0327316A (ja) * | 1989-06-23 | 1991-02-05 | Kitasato Inst:The | 高脂血症治療剤 |
| BRPI0615974A2 (pt) * | 2005-07-27 | 2011-05-31 | University Of Florida Research Foundation, Inc., | uso de choque térmico para tratar uma doença ocular em um indivìduo, método para recrutar uma célula-tronco para um tecido ocular de um indivìduo com necessidade da mesma, uso de choque térmico para tratar uma doença ou um distúrbio ocular em um indivìduo com necessidade do mesmo, uso de choque térmico para regenerar a retina em um indivìduo com necessidade do mesmo, uso de choque térmico para reparar os danos ao epitélio pgmentar da retina em um indivìduo com necessidade do mesmo, uso de choque térmico para tratar a degeneração macular em um indivìduo com necessidade do mesmo, composição farmacêutica para o recrutamento de células-tronco, composição farmacêutica para recrutamento de células-tronco em um tecido ocular, kit e método para identificar um agente que aumenta o recrutamento de células-tronco em um tecido ocular |
| CN101669939A (zh) * | 2009-09-22 | 2010-03-17 | 中山大学 | 恩镰孢菌素类化合物在制备抗耐药结核菌药物中的应用 |
| US20140275091A1 (en) * | 2013-03-15 | 2014-09-18 | Coyote Pharmaceuticals, Inc. | Ocular formulations comprising geranylgeranylacetone derivatives for intraocular delivery |
| US20140371158A1 (en) * | 2013-06-14 | 2014-12-18 | Georgia Regents University | Beauvericin compositions and methods thereof for inhibiting the hsp90 chaperone pathway |
| CN109200066A (zh) * | 2017-07-07 | 2019-01-15 | 葡萄王生技股份有限公司 | 蝉花活性物质及其用于预防、延缓或治疗白内障的用途 |
-
2020
- 2020-04-01 JP JP2021560499A patent/JP7461663B2/ja active Active
- 2020-04-01 SG SG11202110659SA patent/SG11202110659SA/en unknown
- 2020-04-01 WO PCT/CN2020/082765 patent/WO2020200241A1/en not_active Ceased
- 2020-04-01 CN CN202080025566.3A patent/CN113795268B/zh active Active
- 2020-04-01 TW TW109111356A patent/TWI818168B/zh active
- 2020-04-01 US US16/837,259 patent/US11033603B2/en active Active
- 2020-04-01 EP EP20782491.3A patent/EP3946414B1/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022183183A5 (enExample) | ||
| Reimherr et al. | A multicenter evaluation of the efficacy and safety of 150 and 300 mg/d sustained-release bupropion tablets versus placebo in depressed outpatients | |
| JP2017075173A5 (enExample) | ||
| NZ710575A (en) | Pharmaceutical compositions for the treatment of diabetes mellitus | |
| TN2010000251A1 (fr) | N-acetyl-dl-leucine medicament neuro et retino protecteur | |
| JP2015096532A5 (enExample) | ||
| BRPI0819081A8 (pt) | Formulação oftálmica aquosa, processo para preparar a mesma, e, método para inibir, tratar ou prevenir doenças oculares e doença ou condição relacionada, em um paciente em necessidade de tal tratamento | |
| JP2013500977A5 (enExample) | ||
| JP2017525769A5 (enExample) | ||
| JP2019532926A5 (enExample) | ||
| JP2018529666A5 (enExample) | ||
| JP2023541766A5 (enExample) | ||
| JP2013534527A5 (enExample) | ||
| JP2019532026A5 (enExample) | ||
| JOP20230133A1 (ar) | استخدام منشطات sGC لمعالجة الأمراض العينية | |
| RU2017112930A (ru) | Офтальмологические составы для доставки лекарств и защиты переднего отдела глаза | |
| RU2013137645A (ru) | Аналоги цистамина, применяемые для лечения болезни паркинсона | |
| FI3886917T3 (fi) | Kuparinanoklusterit, niitä sisältävät koostumukset ja neurodegeneratiivisten sairauksien hoito | |
| JP2018511639A5 (enExample) | ||
| JP2008540528A5 (enExample) | ||
| FI2765988T3 (fi) | Silmäkoostumus, joka sisältää bromfenaakkia, jolla on parannettu biologinen hyötyosuus | |
| JP2007527417A5 (enExample) | ||
| Guber et al. | Repeated intrastromal injections of voriconazole in combination with corneal debridement for recalcitrant fungal keratitis–a case series | |
| JP2019502719A5 (enExample) | ||
| CN110753543A (zh) | 用于治疗帕金森氏病的方法和组合物 |